Cargando…
P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428847/ http://dx.doi.org/10.1097/01.HS9.0000969068.95778.ba |
| _version_ | 1785090568233156608 |
|---|---|
| author | Amaya, Maria Mcmahon, Christine Aaron Gutman, Jonathan Schwartz, Marc Sevens, Brett Sohalski, Connor Tobin, Jennifer Smith, Clayton T Jordan, Craig Aaron Pollyea, Daniel |
| author_facet | Amaya, Maria Mcmahon, Christine Aaron Gutman, Jonathan Schwartz, Marc Sevens, Brett Sohalski, Connor Tobin, Jennifer Smith, Clayton T Jordan, Craig Aaron Pollyea, Daniel |
| author_sort | Amaya, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428847 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288472023-08-17 P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) Amaya, Maria Mcmahon, Christine Aaron Gutman, Jonathan Schwartz, Marc Sevens, Brett Sohalski, Connor Tobin, Jennifer Smith, Clayton T Jordan, Craig Aaron Pollyea, Daniel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428847/ http://dx.doi.org/10.1097/01.HS9.0000969068.95778.ba Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Amaya, Maria Mcmahon, Christine Aaron Gutman, Jonathan Schwartz, Marc Sevens, Brett Sohalski, Connor Tobin, Jennifer Smith, Clayton T Jordan, Craig Aaron Pollyea, Daniel P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title | P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title_full | P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title_fullStr | P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title_full_unstemmed | P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title_short | P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML) |
| title_sort | p540: results from a phase 1 clinical study of the all-oral regimen of cc-486 and venetoclax for relapsed and refractory acute myeloid leukemia (aml) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428847/ http://dx.doi.org/10.1097/01.HS9.0000969068.95778.ba |
| work_keys_str_mv | AT amayamaria p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT mcmahonchristine p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT aarongutmanjonathan p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT schwartzmarc p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT sevensbrett p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT sohalskiconnor p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT tobinjennifer p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT smithclayton p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT tjordancraig p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml AT aaronpollyeadaniel p540resultsfromaphase1clinicalstudyofthealloralregimenofcc486andvenetoclaxforrelapsedandrefractoryacutemyeloidleukemiaaml |